Long-term survival after ovarian cancer diagnosis higher than previously thought
the ONA take:
UC Davis researchers reviewed data collected on thousands of patients with ovarian cancer in California and found that survival rates are higher than predicted for most women. In fact, almost one-third of patients survive at least 10 years after diagnosis.
The study confirmed the factors associated with higher survival, such as younger age, early stage, and lower grade tumor at diagnosis; however, it also found a surprising number of survivors who did not meet that criteria. Most survival studies consider 5-year survival or less; this study looked at 10-year survival.
Of the 11,541 patients in the California Cancer Registry, the database used for the study, 3,582 survived more than 10 years. Furthermore, 954 of those survivors had been considered to be at high risk of dying from their disease.
The researchers’ next step is to figure why so many women who are given a poor prognosis beat their odds. Some theories include women with the BRCA1/2 mutation may respond better to chemotherapy, biological differences in women may affect individual outcomes, or some patients may receive more effective treatment than others.
Survival rates for ovarian cancer are higher than predicted for most women.
- Cholesterol-Lowering Drugs May Prevent Breast Cancer Recurrence
- Blood Test Predicts Stem Cell Transplant Success in Myelodysplastic Syndrome
- Idelalisib Increases Progression-Free Survival in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia
- Trends in Behaviors, Medical Practice Indicate Mortality From Melanoma Will Decline
- Immunotherapy and the Future of Prostate Cancer Treatment
- Survivors Reporting Chronic Neuropathic Pain Struggle to Retain Jobs
- Timing of Chemotherapy Infusion Affects Inflammatory Response to Chemotherapy
- Postoperative Gemcitabine Plus Capecitabine: A New Standard of Care for Pancreatic Cancer
- Blood-Forming Stem Cell Transplants (Fact Sheet)
- Nut Consumption Inversely Associated With Lung Cancer Risk
- Use of Checkpoint Inhibitors in Urothelial Carcinoma
- Chemo + Radiotherapy Efficacious in Muscle-invasive Bladder Cancer
- Elderly with NSCLC Can Tolerate Aggressive Radiation Therapy Treatments
- Colorectal Cancer Risk Higher With Poor Metabolic Health vs Increased Weight
- Best Approach to Infection and Tumor Treatment: Contain or Eliminate?
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|